Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Frontiers in Immunology
|
January 21, 2025
The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer
Rachel Pounds, Wayne Croft, Hayden Pearce, et al.
Cell Reports. Medicine
|
September 8, 2022
Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people
Helen Parry, Rachel Bruton, Reni Ayodele, et al.
Blood Advances
|
July 19, 2024
CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHD
Kriti Verma, Wayne Croft, Sandra Margielewska-Davies, et al.
British Journal of Cancer
|
April 10, 2024
Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
Maryam Arshad, Abul Azad, Phoebe Yuen Ka Chan, et al.
European Journal of Immunology
|
September 26, 2017
NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD
Yuen Ling Tracey Chan, Jianmin Zuo, Charlotte Inman, et al.
Nucleic Acids Research
|
March 18, 2015
Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression
Sharada Ramasubramanyan, Kay Osborn, Rajaei Al-Mohammad, et al.
Frontiers in Endocrinology
|
June 20, 2022
Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality
Maša Mavri, Valentina Kubale, Daniel P Depledge, et al.
Frontiers in Immunology
|
January 11, 2020
Long-Term Ibrutinib Therapy Reverses CD8<sup>+</sup> T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia
Helen M Parry, Nikhil Mirajkar, Natasha Cutmore, et al.
Science Signaling
|
June 1, 2017
A disease-linked <i>ULBP6</i> polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding
Jianmin Zuo, Carrie R Willcox, Fiyaz Mohammed, et al.
Blood Advances
|
March 3, 2019
Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells
Francesca A M Kinsella, Jianmin Zuo, Charlotte F Inman, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Frontiers in Immunology
|
January 21, 2025
The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer
Rachel Pounds, Wayne Croft, Hayden Pearce, et al.
Cell Reports. Medicine
|
September 8, 2022
Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people
Helen Parry, Rachel Bruton, Reni Ayodele, et al.
Blood Advances
|
July 19, 2024
CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHD
Kriti Verma, Wayne Croft, Sandra Margielewska-Davies, et al.
British Journal of Cancer
|
April 10, 2024
Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
Maryam Arshad, Abul Azad, Phoebe Yuen Ka Chan, et al.
European Journal of Immunology
|
September 26, 2017
NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD
Yuen Ling Tracey Chan, Jianmin Zuo, Charlotte Inman, et al.
Nucleic Acids Research
|
March 18, 2015
Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression
Sharada Ramasubramanyan, Kay Osborn, Rajaei Al-Mohammad, et al.
Frontiers in Endocrinology
|
June 20, 2022
Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality
Maša Mavri, Valentina Kubale, Daniel P Depledge, et al.
Frontiers in Immunology
|
January 11, 2020
Long-Term Ibrutinib Therapy Reverses CD8<sup>+</sup> T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia
Helen M Parry, Nikhil Mirajkar, Natasha Cutmore, et al.
Science Signaling
|
June 1, 2017
A disease-linked <i>ULBP6</i> polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding
Jianmin Zuo, Carrie R Willcox, Fiyaz Mohammed, et al.
Blood Advances
|
March 3, 2019
Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells
Francesca A M Kinsella, Jianmin Zuo, Charlotte F Inman, et al.
Page
of 8